These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 668076)

  • 21. The use of an enzyme-linked immunosorbent assay to study the disposition of sheep digoxin-specific immunoglobulin G and Fab fragments in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Clin Exp Immunol; 1988 Dec; 74(3):489-93. PubMed ID: 3233793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hemodynamic effects of the Fab fragment of digoxin antibody (digibind) in corticotropin (ACTH)-induced hypertension.
    Li M; Wen C; Whitworth JA
    Am J Hypertens; 1997 Mar; 10(3):332-6. PubMed ID: 9056691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fab antibody fragments: some applications in clinical toxicology.
    Flanagan RJ; Jones AL
    Drug Saf; 2004; 27(14):1115-33. PubMed ID: 15554746
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analytical control procedures of immunoreactivity for IgG and Fab fragments specific to haptens.
    Cano NJ; Sabouraud AE; Urtizberea M; Carcagne J; Grandgeorge M; Scherrmann JM
    Pharm Res; 1992 May; 9(5):643-7. PubMed ID: 1608896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Digitalis intoxication and treatment with digoxin antibody fragments in renal failure.
    Erdmann E; Mair W; Knedel M; Schaumann W
    Klin Wochenschr; 1989 Jan; 67(1):16-9. PubMed ID: 2921838
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immediate control of life-threatening digoxin intoxication in a child by use of digoxin-specific antibody fragments (Fab).
    Husby P; Farstad M; Brock-Utne JG; Koller ME; Segadal L; Lund T; Ohm OJ
    Paediatr Anaesth; 2003 Jul; 13(6):541-9. PubMed ID: 12846714
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review of clinical experience with digoxin immune Fab (ovine).
    Smith TW
    Am J Emerg Med; 1991 Mar; 9(2 Suppl 1):1-6; discussion 33-4. PubMed ID: 1997014
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reversal of inotropic effects of digoxin by specific antibodies and their Fab fragments in the conscious dog.
    Ochs HR; Vatner SF; Smith TW
    J Pharmacol Exp Ther; 1978 Oct; 207(1):64-71. PubMed ID: 702352
    [No Abstract]   [Full Text] [Related]  

  • 29. Free and total digoxin in serum during treatment of acute digoxin poisoning with Fab fragments: case study.
    Eyer F; Steimer W; Müller C; Zilker T
    Am J Crit Care; 2010 Jul; 19(4):391-87. PubMed ID: 19875723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Antidigoxin Fab-fragments in suicidal digoxin poisoning. Successful treatment of recurrent ventricular fibrillation].
    Weller P; Peters U; Dickmanns HA; Hespe TH; Adam M; Allolio B; Smolarz A; Grabensee B
    Dtsch Med Wochenschr; 1983 Sep; 108(38):1437-40. PubMed ID: 6884234
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reversal of digitalis effects by specific antibodies.
    Larbig D; Raff U; Haasis R
    Pharmacology; 1979; 18(1):1-8. PubMed ID: 368816
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of amiodarone and digoxin specific Fab antibodies in digoxin overdosage.
    Nicholls DP; Murtagh JG; Holt DW
    Br Heart J; 1985 Apr; 53(4):462-4. PubMed ID: 3986060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of a case of lanatoside C intoxication with digoxin-specific F(ab')2 antibody fragments.
    Hess T; Stucki P; Barandun S; Scholtysik G; Riesen W
    Am Heart J; 1979 Dec; 98(6):767-71. PubMed ID: 495429
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of life-threatening digoxin poisoning with heterologous digoxin-specific antibody fragments].
    Wahl G; Bücking J; Hübner H; Schwartau M
    Dtsch Med Wochenschr; 1983 Sep; 108(38):1441-3. PubMed ID: 6884235
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Severe digoxin intoxication in a child treated by infusion of digoxin-specific Fab-antibody-fragments.
    Rossi R; Leititis JU; Hagel KJ; Smolarz A; Brandis M
    Eur J Pediatr; 1984 Jun; 142(2):138-40. PubMed ID: 6468431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics and efficacy of digoxin specific Fab fragments in a child following massive digoxin overdose.
    Kearns GL; Moss MM; Clayton BD; Hewett DD
    J Clin Pharmacol; 1989 Oct; 29(10):901-8. PubMed ID: 2592582
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Successful treatment of oleander intoxication (cardiac glycosides) with digoxin-specific Fab antibody fragments in a 7-year-old child: case report and review of literature.
    Camphausen C; Haas NA; Mattke AC
    Z Kardiol; 2005 Dec; 94(12):817-23. PubMed ID: 16382383
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetic aspects of digoxin-specific Fab therapy in the management of digitalis toxicity.
    Ujhelyi MR; Robert S
    Clin Pharmacokinet; 1995 Jun; 28(6):483-93. PubMed ID: 7656506
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reversal of toxic and non-toxic effects of digoxin by digoxin-specific Fab fragments in isolated human ventricular myocardium.
    Näbauer M; Erdmann E
    Klin Wochenschr; 1987 Jul; 65(12):558-61. PubMed ID: 3041099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Electrocardiographic response of digoxin-toxic fascicular tachycardia to Fab fragments: implications for tachycardia mechanism.
    Wieland JM; Marchlinski FE
    Pacing Clin Electrophysiol; 1986 Sep; 9(5):727-38. PubMed ID: 2429280
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.